#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13862	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2216	623.3	0	.	n	.	0	A69G	SNP	69	69	A	375	375	G	809	G	744	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13862	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2216	623.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1756	1756	T	797	T	717	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13862	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2216	623.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1490	1490	C	819	C	764	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25306	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3506	718.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1588	1588	A	864	A	802	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25306	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3506	718.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2222	2222	C	827	C	773	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25306	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3506	718.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2296	2296	A	818	A	774	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25306	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3506	718.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2848	2848	C	809	C	750	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2050	folP	852	852	99.88	folP.l15.c30.ctg.1	1593	128.0	0	.	p	.	0	E151K	NONSYN	451	453	GAA	810	812	AAA	202;203;205	A,G;A;A	190,1;192;194	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2050	folP	852	852	99.88	folP.l15.c30.ctg.1	1593	128.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1041	1043	AGC	193;194;194	A;G;C	180;180;176	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5156	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3360	152.9	1	SNP	p	S91F	0	.	.	271	273	TCC	527	529	TCC	152;152;154	T;C;C	144;142;145	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5156	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3360	152.9	1	SNP	p	D95N	0	.	.	283	285	GAC	539	541	GAC	152;152;154	G;A,G;C	142;142,1;144	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5156	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3360	152.9	1	SNP	p	D95G	0	.	.	283	285	GAC	539	541	GAC	152;152;154	G;A,G;C	142;142,1;144	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1668	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1166	142.0	1	SNP	p	G45D	0	.	.	133	135	GGC	364	366	GGC	208;206;206	G;G,T;C	197;192,1;194	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	810	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1023	78.8	0	.	n	.	0	A197.	DEL	197	197	A	590	590	A	188	A	174	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4584	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2910	157.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1606	1608	GCA	192;193;194	G;C,T;A,G	172;174,1;171,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4584	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2910	157.1	1	SNP	p	D86N	0	.	.	256	258	GAC	559	561	GAC	188;191;192	G;A;C	170;168;174	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4584	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2910	157.1	1	SNP	p	S87W	0	.	.	259	261	AGT	562	564	AGT	193;191;191	A,C;G;T	170,1;174;172	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4584	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2910	157.1	1	SNP	p	S87I	0	.	.	259	261	AGT	562	564	AGT	193;191;191	A,C;G;T	170,1;174;172	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4584	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2910	157.1	1	SNP	p	S87R	0	.	.	259	261	AGT	562	564	AGT	193;191;191	A,C;G;T	170,1;174;172	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4584	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2910	157.1	1	SNP	p	S88P	0	.	.	262	264	TCC	565	567	TCC	189;188;189	T;C;C	172;171;173	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4466	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2622	169.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1562	1564	GGC	236;237;235	G;G;C	217;219;216	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3920	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2677	146.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1409	1411	GCA	213;209;209	G;C;A	200;193;193	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3920	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2677	146.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1412	1414	ATC	209;211;211	A;T;C	194;198;199	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3920	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2677	146.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1424	1426	GTG	210;209;208	G;T;G	200;200;198	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3920	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2677	146.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1424	1426	GTG	210;209;208	G;T;G	200;200;198	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3920	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2677	146.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1928	1930	ACC	218;217;216	A;C;C	199;200;201	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3920	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2677	146.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1982	1984	GCG	181;179;179	G;C;G	158;148;145	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3920	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2677	146.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1982	1984	GCG	181;179;179	G;C;G	158;148;145	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3920	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2677	146.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2105	2107	GGC	166;167;167	G;G;C	152;152;154	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3920	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2677	146.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2114	2116	GGC	169;161;161	G;G;C	153;145;148	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3920	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2677	146.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2132	2134	CTG	157;156;158	C,G;TG,TGG;G	125,5;125,1;122	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5608	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3002	186.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1592	1594	CCG	220;218;216	C;C,T;G	195;198,1;191	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2088	porA	1146	1146	99.65	porA.l15.c30.ctg.1	1930	107.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	572	572	C	160	C	147	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1475	187.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	406	408	GAA	206;208;214	G;A;A	197;199;206	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1475	187.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	694	696	GAT	217;220;220	G;A;T	204;204;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1475	187.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	817	819	TCA	229;230;233	T;C;A	216;219;222	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1475	187.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	946	948	GTC	235;234;234	G;T;C	216;215;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1475	187.1	0	.	p	.	0	W257L	NONSYN	769	771	TGG	1063	1065	TTG	242;237;239	T,A,C;T;G	225,1,1;222;224	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1475	187.1	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1066	1068	CAT	241;243;244	C,A;A,G;T,C	225,1;228,1;227,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1475	187.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1276	1278	GCA	214;216;219	G;C,A;A,C	197;198,1;201,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1475	187.1	1	SNP	p	G120K	1	.	.	358	360	AAG	652	654	AAG	205;204;205	A;A;G	189;189;190	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1475	187.1	1	SNP	p	D121N	0	.	.	361	363	GAC	655	657	GAC	206;207;207	G;A;C	191;189;189	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2778	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1475	187.1	1	SNP	p	A121D	1	.	.	361	363	GAC	655	657	GAC	206;207;207	G;A;C	191;189;189	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10248	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4666	218.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1845	1847	CAT	226;224;229	C;A;T	213;209;215	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1242	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	977	126.2	1	SNP	p	V57M	1	.	.	169	171	ATG	458	460	ATG	264;265;265	A;T;G	250;253;253	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
